- Filed
- May 8, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2026 · May 4, 2026 | 46.09M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2026 | 46.06M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2026 | 46M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2025 | 45.73M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2025 | 45.66M sh |
| Capex | Q2 2026 · Mar 31, 2026 | $13.6M |
| Capex | Q2 2026 · Mar 31, 2025 | $15.16M |
| Operating Cash Flow | Q2 2026 · Mar 31, 2026 | $34.36M |
| Operating Cash Flow | Q2 2026 · Mar 31, 2025 | $44.2M |
| Cash And Equivalents | Q2 2026 · Mar 31, 2026 | $234.03M |
| Cash And Equivalents | Q2 2026 · Sep 30, 2025 | $279.78M |
| Stockholders Equity | Q2 2026 · Mar 31, 2026 | $1.55B |
| Stockholders Equity | Q2 2026 · Dec 31, 2025 | $1.71B |
| Stockholders Equity | Q2 2026 · Sep 30, 2025 | $1.73B |
| Stockholders Equity restated | Q2 2026 · Mar 31, 2025 | $1.7B |
| Stockholders Equity restated | Q2 2026 · Dec 31, 2024 | $1.72B |
| Stockholders Equity restated | Q2 2026 · Sep 30, 2024 | $1.77B |
| Current Liabilities | Q2 2026 · Mar 31, 2026 | $257.19M |
| Current Liabilities | Q2 2026 · Sep 30, 2025 | $237.67M |
| Total Liabilities | Q2 2026 · Mar 31, 2026 | $349.21M |
| Total Liabilities | Q2 2026 · Sep 30, 2025 | $332.6M |
| Current Assets | Q2 2026 · Mar 31, 2026 | $726.99M |
| Current Assets | Q2 2026 · Sep 30, 2025 | $708.34M |
| Total Assets | Q2 2026 · Mar 31, 2026 | $1.9B |
| Total Assets | Q2 2026 · Sep 30, 2025 | $2.06B |
| Eps Diluted | Q2 2026 · Mar 31, 2026 | −$3.49 |
| Eps Diluted | Q2 2026 · Mar 31, 2026 | −$3.83 |
| Eps Diluted restated | Q2 2026 · Mar 31, 2025 | −$1.04 |
| Eps Diluted restated | Q2 2026 · Mar 31, 2025 | −$1.29 |
| Eps Basic | Q2 2026 · Mar 31, 2026 | −$3.49 |
| Eps Basic | Q2 2026 · Mar 31, 2026 | −$3.83 |
| Eps Basic restated | Q2 2026 · Mar 31, 2025 | −$1.04 |
| Eps Basic restated | Q2 2026 · Mar 31, 2025 | −$1.29 |
| Sga Expense | Q2 2026 · Mar 31, 2026 | $67.89M |
| Sga Expense | Q2 2026 · Mar 31, 2026 | $128.5M |
| Sga Expense restated | Q2 2026 · Mar 31, 2025 | $69.8M |
| Sga Expense restated | Q2 2026 · Mar 31, 2025 | $139.77M |
| Rd Expense | Q2 2026 · Mar 31, 2026 | $9.43M |
| Rd Expense | Q2 2026 · Mar 31, 2026 | $18.62M |
| Rd Expense restated | Q2 2026 · Mar 31, 2025 | $7.6M |
| Rd Expense restated | Q2 2026 · Mar 31, 2025 | $14.72M |
| Net Income | Q2 2026 · Mar 31, 2026 | −$160.8M |
| Net Income | Q2 2026 · Mar 31, 2026 | −$176.23M |
| Net Income restated | Q2 2026 · Mar 31, 2025 | −$47.66M |
| Net Income restated | Q2 2026 · Mar 31, 2025 | −$58.65M |
| Operating Income | Q2 2026 · Mar 31, 2026 | −$165.79M |
| Operating Income | Q2 2026 · Mar 31, 2026 | −$173.03M |
| Operating Income restated | Q2 2026 · Mar 31, 2025 | −$18.19M |
| Operating Income restated | Q2 2026 · Mar 31, 2025 | −$26.9M |
| Gross Profit | Q2 2026 · Mar 31, 2026 | $62.04M |
| Gross Profit | Q2 2026 · Mar 31, 2026 | $125.74M |
| Gross Profit restated | Q2 2026 · Mar 31, 2025 | $62.78M |
| Gross Profit restated | Q2 2026 · Mar 31, 2025 | $131.6M |
| Revenue | Q2 2026 · Mar 31, 2026 | $144.8M |
| Revenue | Q2 2026 · Mar 31, 2026 | $293.44M |
| Revenue restated | Q2 2026 · Mar 31, 2025 | $143.34M |
| Revenue restated | Q2 2026 · Mar 31, 2025 | $290.77M |